Rigel Pharmaceuticals Stock Widgets and Gadgets
| RIGL Stock | USD 17.88 0.51 2.77% |
| Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- RIGL Rigel Pharmaceuticals
- Latest Rigel settles patent litigation regarding its immune thrombocytopenia treatment
- RIGL 17.88 -0.51
- Low 17.75
- High 18.63
- Alpha 0.27
- Beta 2.12
- Return On Equity -6.99
- Return On Asset 0.11
- Profit Margin 0.1 %
- Operating Margin 0.29 %
- Current Valuation 302.03 M
- Shares Outstanding 17.86 M
- Shares Owned By Insiders 2.84 %
- Shares Owned By Institutions 68.68 %
- Number Of Shares Shorted 1.57 M
- Price To Earning (5.63) X
- Price To Book 97.14 X
- Price To Sales 1.78 X
- Revenue 179.28 M
- Gross Profit 137.25 M
- EBITDA 28.51 M
- Net Income 17.48 M
- Cash And Equivalents 81.64 M
- Cash Per Share 0.47 X
- Total Debt 59.97 M
- Current Ratio 2.34 X
- Book Value Per Share 0.19 X
- Cash Flow From Operations 31.47 M
- Short Ratio 6.95 X
- Earnings Per Share 0.99 X
- Price To Earnings To Growth (0.10) X
- Target Price 33.67
- Number Of Employees 162
- Beta 1.35
- Market Capitalization 319.39 M
- Total Asset 163.98 M
- Retained Earnings (1.39 B)
- Working Capital 71.8 M
- Current Asset 129.02 M
- Current Liabilities 33.8 M
- Net Asset 163.98 M
- Accumulation Distribution 0.0472
- Daily Balance Of Power (0.58)
- Rate Of Daily Change 0.97
- Day Median Price 18.19
- Day Typical Price 18.09
- Market Facilitation Index 0.88
- Price Action Indicator (0.57)
- Period Momentum Indicator (0.51)
- Relative Strength Index 33.15
Market Snapshot Widget Example
DAX Index Germany | 22,462 0.96 | |
Taiwan Weighted Taiwan | 21,603 1.59 | |
PSI 20 Stock Portugal | 6,951 0.75 | |
CROBEX Croatia | 3,329 0.11 | |
Budapest SE Hungary | 91,416 1.41 | |
IDX 30 Jakarta Indonesia | 386.86 0.42 | |
ISEQ 20 Price Ireland | 1,760 1.45 | |
NYSE Comp USA | 19,270 1.35 | |
Tel Aviv 35 Israel | 2,461 0.89 | |
Coreshares Index Tracker South Afric | 1,108 1.95 | |
IPC MEXICO Mexico | 53,173 0.57 | |
KL Technology Malaysia | 50.27 1.32 | |
IBEX 35 Index Spain | 13,309 0.84 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 4,176 2.08 | |
SPASX Dividend Opportunities Australia | 1,661 0.80 | |
HNX 30 Vietnam | 502.01 1.15 | |
Bucharest BET-NG Romania | 1,262 0.07 | |
AMS Small Cap Netherlands | 1,381 0.78 | |
Oslo Exchange Mutual Norway | 1,463 1.34 | |
BEL Small Belgium | 8,418 0.15 | |
Basic Materials Brazil | 5,422 1.55 | |
Swiss Leader Price Switzerland | 2,074 0.42 | |
Fondo Mutuo ETF Chile | 1,563 0.48 | |
Athens General Comp Greece | 1,736 0.6 | |
Stock Exchange Of Thailand | 1,175 1.05 | |
PX Prague Stock Czech Repub | 2,119 1.22 | |
THE PHILIPPINE STOCK Philippines | 6,147 0.13 | |
WIG 30 Poland | 3,505 1.04 | |
BIST Electricity Turkey | 465.96 1.39 |
Investing Ideas
In addition to having Rigel Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Rigel Pharmaceuticals
Compare Rigel Pharmaceuticals To Peers
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rigel Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. For more information on how to buy Rigel Stock please use our How to buy in Rigel Stock guide.You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rigel Pharmaceuticals. If investors know Rigel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rigel Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 17.867 | Earnings Share 0.99 | Revenue Per Share | Quarterly Revenue Growth 0.609 | Return On Assets |
The market value of Rigel Pharmaceuticals is measured differently than its book value, which is the value of Rigel that is recorded on the company's balance sheet. Investors also form their own opinion of Rigel Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Rigel Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rigel Pharmaceuticals' market value can be influenced by many factors that don't directly affect Rigel Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Rigel Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Rigel Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rigel Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.